Regulus Therapeutics Announces Appointment of Preston S. Klassen, M.D. to its Board of Directors

SAN DIEGO, June 23, 2023 -- (Healthcare Sales & Marketing Network) -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs (the "Company" or &q... Biopharmaceuticals, Personnel Regulus Therapeutics, microRNA, Autosomal Dominant Polycystic Kidney Disease
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news